Rayonier (RYN) Competitors $24.38 +0.84 (+3.55%) Closing price 03:58 PM EasternExtended Trading$24.36 -0.03 (-0.10%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RYN vs. PCH, BCC, KIM, WY, OHI, CUBE, RHP, HR, EPR, and SBRAShould you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Potlatch (PCH), Boise Cascade (BCC), Kimco Realty (KIM), Weyerhaeuser (WY), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), and Sabra Healthcare REIT (SBRA). Rayonier vs. Its Competitors Potlatch Boise Cascade Kimco Realty Weyerhaeuser Omega Healthcare Investors CubeSmart Ryman Hospitality Properties Healthcare Realty Trust EPR Properties Sabra Healthcare REIT Potlatch (NASDAQ:PCH) and Rayonier (NYSE:RYN) are both mid-cap construction companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Which has more risk & volatility, PCH or RYN? Potlatch has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Rayonier has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Is PCH or RYN more profitable? Rayonier has a net margin of 30.09% compared to Potlatch's net margin of 4.35%. Rayonier's return on equity of 3.29% beat Potlatch's return on equity.Company Net Margins Return on Equity Return on Assets Potlatch4.35% 2.36% 1.46% Rayonier 30.09%3.29%1.74% Do institutionals and insiders hold more shares of PCH or RYN? 86.1% of Potlatch shares are owned by institutional investors. Comparatively, 89.1% of Rayonier shares are owned by institutional investors. 1.0% of Potlatch shares are owned by insiders. Comparatively, 0.8% of Rayonier shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to PCH or RYN? In the previous week, Rayonier had 2 more articles in the media than Potlatch. MarketBeat recorded 21 mentions for Rayonier and 19 mentions for Potlatch. Rayonier's average media sentiment score of 1.05 beat Potlatch's score of 0.26 indicating that Rayonier is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Potlatch 4 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rayonier 9 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, PCH or RYN? Rayonier has higher revenue and earnings than Potlatch. Rayonier is trading at a lower price-to-earnings ratio than Potlatch, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPotlatch$1.06B3.09$21.88M$0.6168.51Rayonier$1.26B3.01$359.15M$2.3310.47 Do analysts recommend PCH or RYN? Potlatch currently has a consensus price target of $50.00, suggesting a potential upside of 19.65%. Rayonier has a consensus price target of $27.75, suggesting a potential upside of 13.80%. Given Potlatch's stronger consensus rating and higher probable upside, equities research analysts clearly believe Potlatch is more favorable than Rayonier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Potlatch 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Rayonier 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is PCH or RYN a better dividend stock? Potlatch pays an annual dividend of $1.80 per share and has a dividend yield of 4.3%. Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.5%. Potlatch pays out 295.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rayonier pays out 46.8% of its earnings in the form of a dividend. Rayonier is clearly the better dividend stock, given its higher yield and lower payout ratio. SummaryRayonier beats Potlatch on 11 of the 18 factors compared between the two stocks. Get Rayonier News Delivered to You Automatically Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RYN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RYN vs. The Competition Export to ExcelMetricRayonierBLDG PRD IndustryConstruction SectorNYSE ExchangeMarket Cap$3.80B$10.02B$9.39B$20.82BDividend Yield4.63%2.25%2.06%3.65%P/E Ratio10.4726.3916.1327.78Price / Sales3.012.03107.8555.34Price / Cash16.7013.5514.8117.94Price / Book2.042.544.544.65Net Income$359.15M$297.37M$620.50M$993.55M7 Day Performance4.93%3.21%2.56%2.22%1 Month Performance8.21%5.80%5.10%7.67%1 Year Performance-17.34%-14.55%97.13%12.22% Rayonier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RYNRayonier4.2712 of 5 stars$24.39+3.5%$27.75+13.8%-19.5%$3.80B$1.26B10.47420Positive NewsDividend AnnouncementPCHPotlatch4.2957 of 5 stars$40.50-0.2%$48.86+20.6%-3.8%$3.18B$1.10B66.391,383Upcoming EarningsBCCBoise Cascade4.8093 of 5 stars$89.50-1.8%$120.17+34.3%-36.2%$3.37B$6.62B11.177,560Analyst RevisionKIMKimco Realty3.9452 of 5 stars$21.71+1.0%$24.70+13.8%+1.8%$14.68B$2.07B28.19640Positive NewsWYWeyerhaeuser4.2292 of 5 stars$25.90-1.6%$33.13+27.9%-16.8%$18.78B$7.12B51.799,440Upcoming EarningsAnalyst ForecastOHIOmega Healthcare Investors3.499 of 5 stars$38.38+2.2%$42.25+10.1%+5.9%$11.11B$1.08B23.8450Positive NewsCUBECubeSmart3.835 of 5 stars$42.18-0.4%$47.38+12.3%-14.5%$9.61B$929.08M24.963,104Positive NewsRHPRyman Hospitality Properties3.9643 of 5 stars$103.77+0.5%$114.43+10.3%-3.4%$6.23B$2.40B21.981,929Positive NewsAnalyst ForecastHRHealthcare Realty Trust3.5428 of 5 stars$16.00-0.7%$16.40+2.5%-7.2%$5.62B$1.27B-14.67580Positive NewsEPREPR Properties3.6878 of 5 stars$61.20+1.4%$56.43-7.8%+33.0%$4.66B$649.20M37.5460Dividend AnnouncementSBRASabra Healthcare REIT1.2199 of 5 stars$18.76+1.6%$19.67+4.8%+10.2%$4.46B$703.23M31.8040Positive News Related Companies and Tools Related Companies PCH Alternatives BCC Alternatives KIM Alternatives WY Alternatives OHI Alternatives CUBE Alternatives RHP Alternatives HR Alternatives EPR Alternatives SBRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RYN) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rayonier Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rayonier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.